Ignite Creation Date:
2025-12-24 @ 2:55 PM
Ignite Modification Date:
2026-01-27 @ 2:17 AM
Study NCT ID:
NCT00629759
Status:
COMPLETED
Last Update Posted:
2013-01-04
First Post:
2008-02-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic Carcinoma
Sponsor:
Jennerex Biotherapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
JX594-IT-HEP001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
David Kirn, MD, President and CEO
Old Organization:
Jennerex, Inc. (Jennerex Biotherapeutics)
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |